Michael A. Caligiuri
Gründer bei Cytoimmune Therapeutics, Inc.
Aktive Positionen von Michael A. Caligiuri
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
The Ohio University
The Ohio University Other Consumer ServicesConsumer Services Central Hockey League operates a professional minor league hockey teams playing in small to medium-sized markets primarily in central and southwestern US states. The league, which was started in 1992, is managed and operated by WPHL, a subsidiary of Global Entertainment Corporation. | Corporate Officer/Principal | - | - |
The Ohio State University Wexner Medical Center
The Ohio State University Wexner Medical Center Medical/Nursing ServicesHealth Services The Ohio State University Wexner Medical Center provides healthcare services. It offers health and wellness services, health care services such as allergy immunology care, arthritis rheumatology, brain and spine, orthopedics, palliative care, transplant center and wound healing. The company was founded in 1834 and is headquartered in Columbus, OH. | Direktor/Vorstandsmitglied | - | - |
Pelotonia
Pelotonia Miscellaneous Commercial ServicesCommercial Services Pelotonia engages in fund life-saving cancer research. It focuses on end to cancer. The company was founded in 2008 and is headquartered in Columbus, OH. | Direktor/Vorstandsmitglied | - | - |
Cytoimmune Therapeutics, Inc.
Cytoimmune Therapeutics, Inc. BiotechnologyHealth Technology Cytoimmune Therapeutics, Inc. is a clinical-stage biotechnology company founded in 2017 and based in Toa, Japan. The American company is focused on developing a pipeline of NK cell therapies for various types of cancer, including lung cancer, acute myeloid leukemia, solid tumors, and multiple myeloma. The private company's lead product, Cyto-102, is a track-NK cell therapy that aims to enter clinical trials in combination with atezolizumab for non-small cell lung cancer in 2022. Cytoimmune Therapeutics also offers cell therapy development and clinical manufacturing services to biotechnology companies and academia. The company's state-of-the-art clinical cell manufacturing facility is custom-built to support the development and commercialization of cutting-edge T cell or NK cell therapies. The company was founded in 2017 by Michael A. Caligiuri, William Michael Rosellini, and Jianhua Yu, Ph.D. José Eduardo Vidal has been the CEO of the company since 2021. | Technik-/Wissenschafts-/F&E-Leiter | 01.06.2019 | - |
Gründer | 01.06.2019 | - |
Karriereverlauf von Michael A. Caligiuri
Ehemalige bekannte Positionen von Michael A. Caligiuri
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
American Association for Cancer Research
American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services American Association for Cancer Research prints and publishes scientific journals including clinical cancer research, molecular cancer therapeutics, molecular cancer research, cancer epidemiology, and biomarkers and prevention. The company was founded on May 7, 1907 and is headquartered in Philadelphia, PA. | Direktor/Vorstandsmitglied | - | - |
Präsident | - | 18.04.2018 | |
James Cancer Hospital
James Cancer Hospital Hospital/Nursing ManagementHealth Services James Cancer Hospital operates cancer hospitals. The private company is based in Dublin, OH. | Vorstandsvorsitzender | - | 15.11.2017 |
City of Hope National Medical Center
City of Hope National Medical Center BiotechnologyHealth Technology City of Hope National Medical Center is an independent biomedical, treatment, and education center that focuses on basic and clinical research in cancer, diabetes, and other chronic, life-threatening diseases. The non-profit company is based in Duarte, CA. City of Hope offers virtual tours of its world-renowned facilities, where people can learn about the company's efforts to make a difference in the lives of those with serious illnesses such as cancer and diabetes. The company was founded in 1913. Robert W. Stone has been the CEO of the company since 1996. | Präsident | - | - |
Ohio State University Comprehensive Cancer Center
Ohio State University Comprehensive Cancer Center Miscellaneous Commercial ServicesCommercial Services Ohio State University Comprehensive Cancer Center provides cancer care services. It Specializes in cancer care and treatment, cancer types, benign blood diseases, cancer clinics and centers, clinical services, nursing at OSUCCC – james, genetic counseling, find a clinical trial, find a doctor, online bill pay, OSU MyChart and referring physicians. The company was founded by Arthur G. James in 1973 and is headquartered in Columbus, OH. | Direktor/Vorstandsmitglied | - | - |
Vorstandsvorsitzender | - | - | |
INNATE PHARMA | Direktor/Vorstandsmitglied | 28.06.2013 | - |
Statistik
International
Vereinigte Staaten | 9 |
Frankreich | 2 |
Operativ
Director/Board Member | 5 |
Chief Executive Officer | 2 |
President | 2 |
Sektoral
Health Technology | 4 |
Commercial Services | 4 |
Health Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
INNATE PHARMA | Health Technology |
Private Unternehmen | 7 |
---|---|
James Cancer Hospital
James Cancer Hospital Hospital/Nursing ManagementHealth Services James Cancer Hospital operates cancer hospitals. The private company is based in Dublin, OH. | Health Services |
American Association for Cancer Research
American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services American Association for Cancer Research prints and publishes scientific journals including clinical cancer research, molecular cancer therapeutics, molecular cancer research, cancer epidemiology, and biomarkers and prevention. The company was founded on May 7, 1907 and is headquartered in Philadelphia, PA. | Commercial Services |
The Ohio State University Wexner Medical Center
The Ohio State University Wexner Medical Center Medical/Nursing ServicesHealth Services The Ohio State University Wexner Medical Center provides healthcare services. It offers health and wellness services, health care services such as allergy immunology care, arthritis rheumatology, brain and spine, orthopedics, palliative care, transplant center and wound healing. The company was founded in 1834 and is headquartered in Columbus, OH. | Health Services |
Ohio State University Comprehensive Cancer Center
Ohio State University Comprehensive Cancer Center Miscellaneous Commercial ServicesCommercial Services Ohio State University Comprehensive Cancer Center provides cancer care services. It Specializes in cancer care and treatment, cancer types, benign blood diseases, cancer clinics and centers, clinical services, nursing at OSUCCC – james, genetic counseling, find a clinical trial, find a doctor, online bill pay, OSU MyChart and referring physicians. The company was founded by Arthur G. James in 1973 and is headquartered in Columbus, OH. | Commercial Services |
Pelotonia
Pelotonia Miscellaneous Commercial ServicesCommercial Services Pelotonia engages in fund life-saving cancer research. It focuses on end to cancer. The company was founded in 2008 and is headquartered in Columbus, OH. | Commercial Services |
City of Hope National Medical Center
City of Hope National Medical Center BiotechnologyHealth Technology City of Hope National Medical Center is an independent biomedical, treatment, and education center that focuses on basic and clinical research in cancer, diabetes, and other chronic, life-threatening diseases. The non-profit company is based in Duarte, CA. City of Hope offers virtual tours of its world-renowned facilities, where people can learn about the company's efforts to make a difference in the lives of those with serious illnesses such as cancer and diabetes. The company was founded in 1913. Robert W. Stone has been the CEO of the company since 1996. | Health Technology |
Cytoimmune Therapeutics, Inc.
Cytoimmune Therapeutics, Inc. BiotechnologyHealth Technology Cytoimmune Therapeutics, Inc. is a clinical-stage biotechnology company founded in 2017 and based in Toa, Japan. The American company is focused on developing a pipeline of NK cell therapies for various types of cancer, including lung cancer, acute myeloid leukemia, solid tumors, and multiple myeloma. The private company's lead product, Cyto-102, is a track-NK cell therapy that aims to enter clinical trials in combination with atezolizumab for non-small cell lung cancer in 2022. Cytoimmune Therapeutics also offers cell therapy development and clinical manufacturing services to biotechnology companies and academia. The company's state-of-the-art clinical cell manufacturing facility is custom-built to support the development and commercialization of cutting-edge T cell or NK cell therapies. The company was founded in 2017 by Michael A. Caligiuri, William Michael Rosellini, and Jianhua Yu, Ph.D. José Eduardo Vidal has been the CEO of the company since 2021. | Health Technology |
- Börse
- Insiders
- Michael A. Caligiuri
- Erfahrung